Poor Oral Health and Diabetes: The Workplace Link Hiding in a Blood Test

Why Employers Should Be Paying Attention

When leaders think about metabolic health, they think about screening days, nutrition and movement. Almost none think about their employees' oral health. Yet endocrinologists, periodontal researchers and Cochrane increasingly do.

This is Report 4 in the Smile™ Enterprise Oral Health Series. It covers 10 metabolic and endocrine conditions, from type 2 diabetes to iron deficiency, all of them linked in the research literature to the state of a person's mouth — and every one of them measurable on a blood test.

One Preventable Condition, More Than 50 Linked Chronic Conditions

Poor oral health is linked to more than 50 chronic conditions. The six below are the most significant for Australian workforces, and each has, or will have, its own report in this series — this report covers the 4th.

Ten Markers, One Mouth

Below is the whole report in one table. Ten metabolic and endocrine conditions, what the research associates each one with, and how strong that evidence actually is. Everything that follows is this panel, explained.

How to Read the Grades

STRONG means decades of consistent evidence across multiple study designs, including prospective cohorts and intervention trials.

MODERATE means consistent association across several meta-analyses, but with meaningful limitations — cross-sectional designs, heterogeneity, or unresolved direction of effect.

EMERGING means a real signal in the literature that is not yet settled, and in one case is actively contradicted.

We have graded these rather than listing them flat because the evidence for type 2 diabetes and the evidence for altered MCH are not comparable, and presenting them as though they were would not survive scrutiny.

The Glucose Line

Three conditions, one continuum. Insulin resistance is where it starts, type 2 diabetes is where it ends, and gestational diabetes is the same biology surfacing under the metabolic load of pregnancy. This cluster carries the strongest evidence in the entire Oral Health Series.

Here are the three markers, in turn.

One figure anchors the cluster — the same figure that carries this report's card in the series grid:

The Cluster Effect

These four conditions almost never arrive alone. Metabolic syndrome is by definition a cluster — raised waist circumference, raised blood pressure, raised triglycerides, low HDL cholesterol, raised blood glucose. Obesity, abnormal lipids and fatty liver disease are its usual companions. And the periodontal association tracks the clustering precisely.

The Dose–Response Finding

This is the single most interesting result in the cluster. A meta-analysis examining metabolic syndrome component by component found the association with poor oral health climbing in step with the number of components present:

A dose–response gradient like this is what researchers look for when assessing whether an association is likely to be real rather than incidental. It does not prove causation, but it is a meaningfully stronger form of evidence than a single odds ratio, and it explains why this cluster is treated as one thing rather than four.

Here are the four markers in the cluster, one by one.

The Overlooked Markers

The last three markers are the ones no benefits review has ever discussed. Two of them concentrate in the same group of employees: women in their late twenties, thirties and early forties — statistically the most expensive cohort in an organisation to lose and replace.

The figure worth holding onto from this cluster is the two-way PCOS association:

The Two-Way Street

Reports 1 and 2 in this series described one-way pathways from the mouth outward. Report 3 described a cycle. This one is simpler and better evidenced than either: a single mechanism running in both directions at once.

Direction One — From the Mouth to the Bloodstream

Poor oral health is a chronic inflammatory condition covering, at its worst, a surface area inside the mouth comparable to the palm of a hand. That surface is permanently inflamed and permanently in contact with the bloodstream. Inflammatory mediators enter circulation continuously, and those mediators interfere with insulin signalling — reducing the body's sensitivity to its own insulin. The result is higher circulating glucose, and over time, greater strain on the pancreas.

Direction Two — From the Bloodstream Back to the Mouth

Raised blood glucose changes the environment inside the mouth. It impairs the immune response to oral bacteria, slows the healing of gum tissue, and produces advanced glycation end products that make periodontal breakdown more likely and more severe. Which increases the inflammatory load. Which further reduces insulin sensitivity.

This is why the associations in this report are unusually consistent across study designs. It is not one finding replicated; it is a mechanism with a plausible biological explanation, observed from both directions, in cohorts, in case-control studies, and — as the next section covers — in randomised trials.

The Exit Ramp

Everything to this point has been observational. This section is not, and it is the reason this report exists.

In 2022, Cochrane — the international standard-setter for evidence synthesis — published an updated review of randomised controlled trials testing whether treating poor oral health improves blood sugar control in people with diabetes. The 2022 update doubled the number of included studies and changed the review's conclusion.

For context on what that figure means: metformin, the standard first-line diabetes medication, typically lowers HbA1c by 1 to 1.5 percentage points when used on its own. Treating poor oral health delivers roughly a third of that — from a dental appointment rather than a prescription. It is not a substitute for diabetes treatment, and the trials measured it in people who already had both conditions. But no other input in a wellbeing portfolio has been tested this way at all.

This is the claim no other report in this series can make. For cardiovascular disease, cancer and mental health, the honest position is that an association exists and the mechanism is plausible. Here, an intervention was tested, in randomised trials, and it moved a clinical biomarker that every treating clinician in the country already tracks.

What the Trials Do and Do Not Show

Because this finding will be quoted, it is worth being precise about its edges. The table below states them plainly.

The equivalent finding shows up elsewhere in the panel too, though at lower certainty. The 73-study dyslipidaemia review found total cholesterol, triglycerides and HDL all improved three months after periodontal treatment. A separate review in people with type 2 diabetes found reductions in total cholesterol and triglycerides at three months. The pattern is consistent: treat the inflammation in the mouth, and metabolic markers move.

The Silent Decade

Metabolic conditions do not arrive. They accumulate. Insulin resistance can run for years before it registers as anything, which is why Australian screening data keeps finding people who already have the condition and do not know it — the ABS National Health Measures Survey found roughly one newly detected case of diabetes for every six already diagnosed, and Diabetes Australia estimates around 500,000 Australians are living with undiagnosed type 2 diabetes.

What Each Side Reveals About the Other

Because the relationship runs both ways, so do the warning signs. The mouth can indicate metabolic trouble, and metabolic trouble shows up in the mouth. Neither column is diagnostic — both are reasons to see a dentist or a GP.

The Metabolic Budget You're Already Spending — Just Not Where It Works

Most organisations already pay for metabolic health. There's a health check, a biometric screening day, a gym subsidy, a step challenge, maybe healthier options in the kitchen. The intent is right. The problem is what the spend produces: numbers. Blood pressure, waist measurement, cholesterol, blood glucose — measured, reported, and then largely left where they were, because nothing in the portfolio funds an intervention the whole workforce will actually use.

Poor oral health works against that same budget from the other side, and it does so quietly. The employee putting off the dentist on cost grounds is developing poor oral health that runs both ways with blood sugar — feeding the insulin resistance the screening day just measured — while the unpredictable cost of the dental care they're deferring adds to the financial strain at home. None of it shows up as a line item. All of it is already being absorbed.

What This Actually Costs

Metabolic disease is among the most expensive health categories in the country. Diabetes alone accounted for around $4.4 billion in Australian health expenditure in 2023–24, and 1.3 million hospitalisations — 11% of all hospitalisations — were associated with it. And the exposure inside a workforce is larger than the diagnosed numbers suggest, because so much of it is silent: around 500,000 Australians are living with undiagnosed type 2 diabetes, and a further 2 million have prediabetes.

Before any of that, though, the cost lands on talent: whether good people join, and whether they stay. Replacing one employee costs 30% to 200% of their annual salary once recruitment, onboarding and lost ramp-up are counted. A benefit only shifts if employees feel it — and dental is one of the few that does, because it reaches partners and children and gets used routinely, not only in a crisis. This report sharpens the exposure further: metabolic risk builds through exactly the tenure years when employees are most valuable, and three of the ten markers concentrate in women of reproductive age, the cohort most retention strategy is built around.

Where It Surfaces in the Working Day

Poor oral health doesn't wait for a diagnosis to affect work. It shows up first, and daily, in ways that read as ordinary underperformance:

• Energy and focus: Iron deficiency — one of the ten markers, and consistent with the anaemia-of-inflammation pattern seen in poor oral health — presents as fatigue and reduced concentration rather than absence. The employee is at work, but not at their own baseline, and nothing in an attendance report shows it.

• Confidence and participation: More than 35% of Australian adults feel uncomfortable about their dental appearance — the quiet self-consciousness that keeps people off camera, out of the room in client meetings, and back from roles that would stretch them.

• Financial strain: Unpredictable, potentially multi-thousand-dollar dental costs add to cost-of-living pressure and the financial stress carried into work. The dental gap is a financial-stress gap and a deferred-care gap at once — and the deferred care is where the periodontal exposure builds.

• The long absences: Poor oral health is linked to 50+ dental-related chronic conditions, the ten metabolic and endocrine markers in this report among them — and metabolic conditions bring some of the longest, most disruptive absences an employer faces, typically arriving a decade after the risk began building.

The Loss That Never Reaches the P&L

Want the number for your own workforce?

Why Dental Is the Wellbeing Benefit That Gets Used

Dental is a universal, recurring and expensive need. Everyone has teeth, everyone needs routine preventive check-up twice a year for life, and when something goes wrong the cost is unpredictable and can run into thousands. That combination is rare in a benefits portfolio — and it's why enterprise dental cover delivers more than most benefits do.

Enterprise cover means the business funds 100% of the membership, so there's no high, rising annual cover cost for the employee to weigh up. Cover starts from Day 1 for the employee, their partner and dependant children — no waiting periods and no restrictions, and pre-existing conditions covered. Nothing stands between an employee and an appointment. Smile™ then reduces and caps treatment fees across 4,000+ dentists nationwide. For the employee, that's protection from unpredictable dental costs — and one less source of the financial stress this report has traced into the working day. Fund it for everyone at once, and attendance follows:

The three figures below show what happens to dental utilisation when the employer pays — the mechanism that turns cover on paper into attendance in the chair.

Set that against the wellbeing benefit you already fund. Where typical wellbeing uptake sits low, employer-paid dental cover reaches up to 77% of employees in a year. And in this report, using it is the metabolic intervention: Section VI showed that treating poor oral health is the one input in a wellbeing portfolio with randomised-trial evidence of moving a clinical marker — an average 0.43% absolute reduction in HbA1c. Plenty of employees will never act on a screening-day printout, but they'll book a dental check-up — a familiar, non-stigmatised appointment that quietly protects their metabolic health too.

Not just the U.S., in Canada, and a few APAC countries like Singapore and Hong Kong, employer-paid dental cover is a standard part of most large employers' benefits. Up to 86% of employers in these countries provide employer-paid dental cover with utilisation reaching up to 75% in Canada. While in Australia, it's still left to each employee to sort out on their own.

Where Extras Cover and Wellness Perks Fall Short — and Smile™ Doesn't

The Payoff, Across the Business

Each lever below is one this report has touched — and the way enterprise dental cover moves it.